Study of ARC-520 in Patient With Chronic Hepatitis B Virus

Summary

Patients with chronic HBV infection will receive ARC-520 in combination with entecavir or tenofovir and be evaluated for safety and efficacy.

Timeline

Start

2015-02

Primary completion

2015-12

Completion

2016-03

Outcome

Outcome not reported

Stopped: “Company decision to pursue alternative clinical trial”

Drugs

Indications